Back to PO PointState Capital LP

CAI

5 quarters

Position history for POPointState Capital LP's holdings in Caris Life Sciences, Inc.

Yes. PointState Capital holds 6,828,835 shares of CAI (Caris Life Sciences), worth $121.7M, as of its Q2 2026 13F filing. It reduced the position by 531,611 shares (-7.2%) from Q1 2026. PointState Capital has held CAI in every 13F on record since Q2 2025, 5 quarterly filings. CAI is 1.6% of PointState Capital's reported 13F portfolio.

Current Value

$121.7M

Current Shares

6.8M

Total Value Change

+$54.9M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.8M
-7.2%
$121.7M1.6%$17.82
0
2026-Q1
Increased
7.4M
+9.6%
$131.6M1.7%$17.88
53
2025-Q4
Increased
6.7M
+73.0%
$181.3M2.7%$26.98
78
2025-Q3
Increased
3.9M
+55.5%
$117.5M1.8%$30.25
68
2025-Q2
New
2.5M
-
$66.8M1.0%$26.72
69

Other major holders of CAI: FMR LLC, Coatue Management LLC

Optional analytics helps us improve. How it’s used